+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Phase 2
Age: 18Years +
All Genders
ID06721884

Testing Artemisia Annua Herbal Supplement for Adults with Hydrogen-Type Small Intestinal Bacterial Overgrowth in a Phase III Placebo-Controlled Trial

Led by National University of Natural Medicine · Updated on 2025-06-04

32

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Small intestinal bacterial overgrowth SIBO causes symptoms like bloating, stomach pain, and changes in bowel movements, affecting quality of life. This condition is common among people with irritable bowel syndrome IBS. Researchers are studying Artemisia annua, a herb known for its antimicrobial effects against bacteria linked to hydrogen-type SIBO, to evaluate its safety and tolerability in adults with this condition. Participants will take either 5 grams of dried Artemisia annua leaves or a placebo daily for five weeks. The dosing starts with a gradual increase during the first week, reaching full dosage by the second week, and continues for four weeks. The placebo used is dried-leaf alfalfa, matched in weight and appearance to the Artemisia capsules. The study is triple-masked, meaning participants, researchers, and administrators do not know who receives the herb or placebo. During the study, participants will undergo two lactulose breath tests, biweekly blood tests, and regular symptom assessments through questionnaires. Researchers will monitor safety through blood tests, vital signs like heart rate and blood pressure, and any adverse events. Outcomes measured include quality of life, symptom severity, and gas response. The study includes up to 32 adults from the Portland, Oregon area and uses random assignment to treatment groups with close adherence monitoring.

CONDITIONS

Brief Title

Herbal Evaluation Of Artemisia Annua For Small Intestinal Bacterial Overgrowth

Research Team

J

Joshua Z Goldenberg, ND

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here